BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE. (17th June 2021)

• Record Type: Journal Article
• Authors: Ionova, T.; Andrievskikh, M.; Amdiev, A.; Baryakh, E.; Chang, V.; Endakova, A.; Fadeeva, N.; Husainova, G.; Ivanov, V.; Kaplanov, K.; Kaverina, O.; Kiseleva, M.; Klitochenko, T.; Kurakin, V.; Larionova, O.; Lazareva, D.; Lepik, K.; Lysenko, I.; Melnichenko, V.; Mikhailova, N.; Minullina, R.; Mironov, O.; Misyurina, E.; Mochkin, N.; Nikitina, T.; Osipov, Y.; Petrova, T.; Porfirieva, N.; Rukavitsyn, O.; Safin, R.; Samoylova, A.; Shelekhova, T.; Sherstnev, D.; Simashova, P.; Smirnova, E.; Trenina, N.; Vasiliev, E.; Volodicheva, E.;
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.67_2881
• Languages: English
• ISSNs: 0278-0232